Ontology highlight
ABSTRACT: Background
Plasmodium falciparum circumsporozoite protein (CSP) is a leading malaria vaccine candidate antigen, known to elicit protective antibody responses in humans (RTS,S vaccine). Recently, a DNA prime / adenovirus (Ad) vector boost vaccine encoding CSP and a second P. falciparum antigen, apical membrane antigen-1, also elicited sterile protection, but in this case associated with interferon gamma ELISpot and CD8+ T cell but not antibody responses. The finding that CSP delivered by an appropriate vaccine platform likely elicits protective cell-mediated immunity provided a rationale for identifying class I-restricted epitopes within this leading vaccine candidate antigen.Methods
Limited samples of peripheral blood mononuclear cells from clinical trials of the Ad vaccine
SUBMITTER: Sedegah M
PROVIDER: S-EPMC3683343 | biostudies-literature | 2013 Jun
REPOSITORIES: biostudies-literature